Quipt Home Medical Corp.

NasdaqCM:QIPT Stock Report

Market Cap: US$170.5m

Quipt Home Medical Past Earnings Performance

Past criteria checks 0/6

Quipt Home Medical ha aumentado sus ingresos a un ritmo medio anual de 51.5%, mientras que la industria Healthcare ha visto aumentar sus ingresos growing a 9% anualmente. Los ingresos han crecido growing a un ritmo medio anual de 28.3%.

Key information

52.6%

Earnings growth rate

61.4%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate30.1%
Return on equity-3.3%
Net Margin-1.6%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Quipt Home Medical receives commitment letter for $80M of credit facilities

Aug 15

Quipt Business Progresses, Stock Price Should Soon Follow

Jul 26

Quipt acquires Hometown Medical, scoops fourth firm in four months

Jul 11

Quipt: At A Turning Point, Seeking 40% Return Objective

Jun 29

Quipt Convertible Debenture Hedging Provides An Incredible Opportunity

Apr 04

Quipt's Recent Announcements Signal Good Times Ahead

Nov 30

Quipt Home Medical: Acquisitions And Earnings Breathe Life Back Into Shares

Aug 31

Quipt: Warrant Overhang Creates Attractive Prices

Jun 18

Revenue & Expenses Breakdown
Beta

How Quipt Home Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:QIPT Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23236-41190
30 Sep 23212-31090
30 Jun 231890980
31 Mar 231642870
31 Dec 221397750
30 Sep 221285710
30 Jun 221182680
31 Mar 221098630
31 Dec 2199-10540
30 Sep 2194-6500
30 Jun 2187-5420
31 Mar 2181-14390
31 Dec 20791390
30 Sep 2073-4390
30 Jun 20670380
31 Mar 2062-6360
31 Dec 1963-11380
30 Sep 1961-7340
30 Jun 1957-27300
31 Mar 1956-18290
31 Dec 1853-20290
30 Sep 1855-7310
30 Jun 1859-6410
31 Mar 1859-7430
31 Dec 1761-4410
30 Sep 1761-22410
30 Jun 1736-16270
31 Mar 1745-19370
31 Dec 1656-29510
30 Sep 1673-28600
30 Jun 16105-18740
31 Mar 1694-25640
31 Dec 1573-16440
30 Sep 1554-18340
30 Jun 1542-21260
31 Mar 1530-7160
31 Dec 1425-4150
30 Sep 1419-1110
30 Jun 1412060
31 Mar 147-140
31 Dec 135-230
30 Sep 134-220
30 Jun 134020

Beneficios de calidad: QIPT actualmente no es rentable.

Creciente margen de beneficios: QIPT actualmente no es rentable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Tendencia de beneficios: QIPT no es rentable, pero ha reducido pérdidas en los últimos 5 años a un ritmo de 51.5% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de QIPT en el último año con su media de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: QIPT no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el del sector Healthcare (0.3%).


Return on Equity

Alto ROE: QIPT tiene un Rendimiento de los fondos propios negativo (-2.51%), ya que actualmente no es rentable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.